Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bioxydyn Ltd.
DescriptionDynamic contrast-enhanced MRI
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsAssess the change in tumour vascular status in response to antiangiogenic and vascular disrupting therapies
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today